X
API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.clinicaltrialsarena.com/news/imago-myelofibrosis-treatment-trial/
https://www.globenewswire.com/news-release/2022/12/20/2577487/0/en/Imago-BioSciences-Announces-First-Participant-Dosed-in-Investigator-Sponsored-Phase-2-Study-of-Bomedemstat-in-Combination-with-Ruxolitinib-in-Myelofibrosis.html
https://www.globenewswire.com//news-release/2022/12/12/2572137/0/en/Imago-BioSciences-Presents-Positive-Data-from-Ongoing-Phase-2-Study-of-Bomedemstat-in-Essential-Thrombocythemia-at-ASH-2022.html
https://www.globenewswire.com//news-release/2022/11/30/2565433/0/en/Imago-BioSciences-Announces-First-Participant-Dosed-in-Investigator-Sponsored-Phase-1-Study-of-Bomedemstat-in-Combination-with-Venetoclax-in-Relapsed-Refractory-Acute-Myeloid-Leuke.html
https://ir.imagobio.com/news-releases/news-release-details/merck-acquire-imago-biosciences-inc
https://www.globenewswire.com/news-release/2022/05/09/2438532/0/en/Imago-BioSciences-Announces-First-Participant-Dosed-in-Investigator-Sponsored-Study-of-Bomedemstat-in-Combination-with-Atezolizumab-in-Small-Cell-Lung-Cancer.html
https://www.globenewswire.com/news-release/2022/05/03/2434543/0/en/Imago-BioSciences-Announces-Completion-of-Enrollment-in-Phase-2-Clinical-Study-of-Bomedemstat-in-Essential-Thrombocythemia.html
Market Place
Share 
